de Vere White RW - Search Results

1

Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells.

Batra N, Sam A, Woldemariam T, Talbott G, de Vere White RW, Ghosh PM, Gaikwad NW, Kotchoni SO, Vinall RL. Batra N, et al. Among authors: de vere white rw. Biomedicines. 2020 Aug 11;8(8):282. doi: 10.3390/biomedicines8080282. Biomedicines. 2020. PMID: 32796613 Free PMC article.

2

Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.

Tepper CG, Gregg JP, Shi XB, Vinall RL, Baron CA, Ryan PE, Desprez PY, Kung HJ, deVere White RW. Tepper CG, et al. Prostate. 2005 Dec 1;65(4):375-89. doi: 10.1002/pros.20308. Prostate. 2005. PMID: 16037992

3

The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7.

Vinall RL, Tepper CG, Shi XB, Xue LA, Gandour-Edwards R, de Vere White RW. Vinall RL, et al. Among authors: de vere white rw. Oncogene. 2006 Mar 30;25(14):2082-93. doi: 10.1038/sj.onc.1209246. Oncogene. 2006. PMID: 16434975

4

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.

Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Tepper CG, et al. Among authors: de vere white rw. Prostate. 2007 Apr 1;67(5):521-35. doi: 10.1002/pros.20548. Prostate. 2007. PMID: 17252539

5

The oncogenic potential of a prostate cancer-derived androgen receptor mutant.

Shi XB, Xue L, Tepper CG, Gandour-Edwards R, Ghosh P, Kung HJ, DeVere White RW. Shi XB, et al. Prostate. 2007 May 1;67(6):591-602. doi: 10.1002/pros.20544. Prostate. 2007. PMID: 17262801

6

A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells.

Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, deVere White RW, Ghosh PM. Wang Y, et al. Oncogene. 2007 Sep 6;26(41):6061-70. doi: 10.1038/sj.onc.1210435. Epub 2007 Apr 9. Oncogene. 2007. PMID: 17420725

7

Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.

Liu S, Vinall RL, Tepper C, Shi XB, Xue LR, Ma AH, Wang LY, Fitzgerald LD, Wu Z, Gandour-Edwards R, deVere White RW, Kung HJ. Liu S, et al. Oncogene. 2008 Jan 17;27(4):499-505. doi: 10.1038/sj.onc.1210671. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653089

8

Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis.

Vinall RL, Hwa K, Ghosh P, Pan CX, Lara PN Jr, de Vere White RW. Vinall RL, et al. Among authors: de vere white rw. Clin Cancer Res. 2007 Oct 15;13(20):6204-16. doi: 10.1158/1078-0432.CCR-07-0600. Clin Cancer Res. 2007. PMID: 17947488

9

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.

Wang Y, Mikhailova M, Bose S, Pan CX, deVere White RW, Ghosh PM. Wang Y, et al. Oncogene. 2008 Nov 27;27(56):7106-17. doi: 10.1038/onc.2008.318. Epub 2008 Sep 8. Oncogene. 2008. PMID: 18776922 Free PMC article.

10

The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.

Chamie K, Ghosh PM, Koppie TM, Romero V, Troppmann C, deVere White RW. Chamie K, et al. Am J Transplant. 2008 Dec;8(12):2668-73. doi: 10.1111/j.1600-6143.2008.02430.x. Epub 2008 Oct 6. Am J Transplant. 2008. PMID: 18853950 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters